PRIME – Major new initiative to boost Polish research commercialisation

Good performance in intellectual assets but low in innovation: How can Poland improve its competitiveness? The FNP emphasizes the importance of research commercialization

PRIME Project – Science Commercialization Support 

The PRIME Project is aimed at scientists working in Polish research organisations who, by forming project teams, want to verify the market potential, as well as develop and implement the most appropriate commercialisation path for their ideas, including through the set-up of a spin-off. 

The project is run in partnership by the Foundation for Polish Science and Oxentia Ltd. 

The project receives funding through the European Funds for Smart Economy (FENG) programme. 

Goals 

The PRIME grant project will support teams in: 

• Development of cooperation, commercialisation and business skills 

• Identification and verification of market needs and market readiness of the solution 

• Development of the most appropriate commercialisation path and its implementation 

• Expand their industry networks and create strategic partnerships 

• Setting up and running a spin-off 

The PRIME project is divided into three Phases. 

Phase I (6 months) is targeted at increasing the competencies of the team members and the initial market validation of the defined commercialisation subject. 

Phase II (12 months) is mainly focused on in-depth market verification of the solution, design of the product development and commercialisation strategy and search for an audience. 

Phase III (12 months) is dedicated to spin-off companies established as a result of Phase II. The companies will follow an individual company and product development plan. 

Addressees 

The Applicants for Phase I are research organisations within which Project Teams consisting of: 

1. The Scientific Leader who acts as the main executor of the Grant – the creator or co-creator of the intellectual property that is the basis of the commercialisation subject. This person is the main implementer of the product development and commercialisation vision, 

1. Business Leader – a person who supports the Scientific Leader in relations with the market and market validation of the object of commercialisation, 

1. Technology Transfer Supervisor – the person who supports the Scientific Leader in the development of the commercialisation strategy and is responsible for the development and implementation of the intellectual property protection pathway. 

The tasks dedicated to the team members complement each other and are carried out in mutual collaboration. 

Researchers at any stage of their research career, including before obtaining a degree, can apply for a grant in the PRIME action. 

Applicants to Phase III are companies established as a result of the Project implementing the commercialisation strategy developed by the Team during Phases I and II. 

Funding from EU: 33 mln EURO 

The project receives funding through the European Funds for Smart Economy (FENG) programme. 

03 December 2024 – PRESS RELEASE

In terms of innovation and research and development spending in the European Union, Poland ranks among the last. Nevertheless, Poland performs well in intellectual assets. How can Poland’s potential be harnessed and turned into economic success? The Foundation for Polish Science (FNP) highlights the critical role of research transfer to the market. The FNP has just launched the PRIME project to help scientists bring their research findings to the market. The project receives funding through the European Funds for a Modern Economy (FENG) programme.

According to the European Central Bank’s publication, innovations drive progress and economic growth by creating new opportunities that enhance productivity and competitiveness.[1]

The European Commission’s report entitled “European Innovation Scoreboard 2023” states that Poland ranks poorly in terms of innovation: 25th out of 28 studied countries[2]. At the same time, Poland performs well in intellectual assets dimension, which captures different forms of Intellectual Property Rights (IPR) generated by the innovation process, including PCT patent applications, trademark applications, and design applications. In this category, Poland holds 16th position, outperforming France, Spain, Portugal, Lithuania, Latvia, the Czech Republic, or Ireland, while maintaining the average EU level from 2016. Meanwhile, many EU countries have seen declines in patent applications as well as rights in registration of utility models and industrial designs[3] .

“Poland’s relatively strong position in intellectual assets clearly shows a phenomenon we have observed as an organization working closely with the academic community: our country’s big potential to bring to market products and services based on innovative concepts and research results. The problem is that the ideas that originate from scientific projects often fail to align with current market needs and customer expectations”, says Dr Marcelina Firkowska, Head of the Academic Entrepreneurship Team at the Foundation for Polish Science.

Barriers to Science and Business Collaboration

Knowledge-based economy is the precondition of innovation and competitive advantage. What fuels innovation and jobs creation is entrepreneurship, including academic entrepreneurship[4]. However, the FNP-commissioned study “Collaboration Principles and Relations Between Scientific and Economic Institutions in the TEAM-TECH Programme” indicates several barriers to the development of academic entrepreneurship: intellectual property valuation policies that complicate commercialisation process, insufficient competencies of scientific institutions in managing intellectual property, limited operational capacity of technology transfer centers, etc.[5]

Support for the Transfer of Scientific Research to the Economy: The FNP Launches the PRIME Project

For over 30 years, the Foundation for Polish Science has supported science, including through programmes that aid different aspects of commercialisation and academic entrepreneurship, such as INNOWATOR, VENTURES, IMPULS, and TEAM-TECH. Built on past experiences, the Foundation’s current offer includes complementary programmes that assist academic community members at various stages of the commercialisation process.

To further expand its offer in this respect, the FNP has just launched PRIME, a programme aimed at supporting the commercialisation of science. Designed for research organizations, the project will help scientists introduce their achievements to the market.

PRIME will provide support in forming project teams focused on commercialization, identifying real market needs, and creating development strategies for products that address those needs. Project participants will learn how to prepare offers that respond to actual customer demands and how to devise the most adequate strategies for launching products, including establishing and developing spin-off companies. Project teams will comprise scientific leaders (idea creators), technology transfer officers, and business leaders. Business mentors and industry experts will work with them at every stage to help them verify product-market fit, identify potential customers, and connect with strategic partners. Customised, certified training, workshops, bootcamps, and study visits will strengthen participants’ skills.

“With this project, we created an individualized approach to commercialization. We do not believe in a ‘one size fits all’ model when it comes to transferring research results. Every idea and technology requires a different perspective, knowledge, strategy, network, and communication method to reach potential customers or investors. For this reason, PRIME stands out as Poland’s only tailored acceleration programme for knowledge and technology transfer, offering scholars individual support at every step in the innovation commercialization process – from A to Z,” explains Dr Marcelina Firkowska.

To further reinforce PRIME’s practical nature, the FNP engaged in collaboration with Oxentia, a British consulting firm. The firm brings expertise from Oxford’s science commercialization environment and extensive international practical experience in intellectual asset management, knowledge and technology transfer, intellectual property valuation, spinoff creation, and securing additional funding for academic enterprises. The firm’s expert practitioners will mentor and train participants.

“At Oxentia, our mission is to bring new ideas to life. With a proven track record of working alongside thousands of academic entrepreneurs, founders, and technology transfer offices (TTOs) around the world, we’ve empowered them to create successful and impactful ventures. While our roots are in Oxford’s rich tradition of technology transfer, our work spans more than 80 countries, embodying the principle that there is no “one-size-fits-all” approach, as reflected in the philosophy of PRIME.

For the PRIME program, we are delivering a fully customized approach designed to provide impactful support to academic staff, entrepreneurs, and TTOs. Our goal is to equip them with the skills, strategies, and insights required to excel in today’s dynamic and interconnected global landscape. We are thrilled to collaborate with FNP to foster innovation and advance entrepreneurial success in Poland, leveraging the country’s outstanding research potential and strengthening its position on the global stage”, says Dr Steve Cleverley, Oxentia CEO.

PRIME will create opportunities for participants to establish effective collaborations with businesses entities. In turn, the collaborations will increase market awareness and develop promising technologies ready for licensing or sale. Moreover, the project will support socially engaged services provided by research organisations. “We also hope that the programme will lead to well-conceived spin-off companies that will implement project-developed technologies with reduced business risk in the future,” adds Firkowska. The programme’s most significant outcome will probably be creation of highly skilled personnel in Polish scientific institutions, including those lacking professional support from technology transfer centers. This will create long-term benefits, contributing to Poland’s innovation growth for many years to come.

The PRIME project receives funding through the European Funds for a Modern Economy (FENG) programme. The Foundation for Polish Science is the beneficiary of the programme.

The details of the first application round for the project will be announced at the beginning of December 2024.

***

Dr Marcelina Firkowska is Head of the Academic Entrepreneurship Team and the PRIME Project Manager at the Foundation for Polish Science (FNP). Her expertise includes the commercialization of scientific research findings.

Firkowska specializes in intellectual property (IP) management and protection, IP valuation, licensing agreements, spin-off creation, and regulating collaboration with entrepreneurs. She is a graduate of the prestigious International Visitor Leadership Program (IVLP) of the US Department of State. She holds a Ph.D. in neurobiology and has experience as an active researcher.

Dr Steve Cleverley is the CEO of Oxentia Ltd, Managing Director of Oxentia Europe SL, and Director of the Oxentia Foundation. Since spearheading Oxentia’s management buyout in 2017, Steve has driven its expansion into 70+ countries, transforming the organisation into a global leader in innovation consulting across Higher Education, Corporate, and Government sectors. With over 28 years of expertise in sales, marketing, and strategic innovation, he has led high-impact projects such as the creation of new universities in Oman and Vietnam, running international technology accelerators, and driving corporate innovation initiatives. Steve holds a BA in Biochemistry from the University of Oxford, a PhD in Immunology from UCL, and an MBA from Henley Business School.

***

The Foundation for Polish Science has been in operation since 1991. It is a non-governmental, independent, self-financing non-profit organization, which pursues the mission of supporting science. It is the largest source of science funding in Poland outside of the state budget. The FNP’s statutory goals include supporting outstanding scholars and research teams as well as fostering the transfer of scientific achievements into economic practice. The Foundation pursues these goals by granting individual awards and scholarships to scientists, providing subsidies for the implementation of scientific achievements in economic practice, and aiding other important initiatives for science, such as publishing programmes and conferences. The Foundation also promotes international scientific cooperation and greater independence of the younger generation of researchers. www.fnp.org.pl

Oxentia is a leading global innovation consultancy that empowers organisations, individuals, and ecosystems to transform ideas into impactful ventures. Established with roots in the University of Oxford’s renowned technology transfer expertise, Oxentia operates independently to deliver tailored solutions across Higher Education, Corporate, and Government sectors. With a presence in over 70 countries, the company is committed to driving innovation and positive change worldwide. For startups and spinouts, Oxentia offers venture support, helping entrepreneurs accelerate their journey from concept to market through business planning, funding strategy, and access to a global network of partners, investors and more.

Press kit

FNP_PRIME Project_press release

PRIME Project – graphics

Marcelina Firkowska – FNP – photo

Steve Cleverley – Oxentia – photo

Sources